The same four observations appear in two supplier audit reports three years apart.
After the first audit the report goes to the supplier, a reply comes back saying the points are noted, and the file is closed because the audit program counts audits performed. Closing the observations is nobody's task.
In its paragraph on audits of active substance manufacturers and distributors, EU GMP Chapter 5 says the report should fully reflect what was done and seen, with any deficiencies clearly identified, and that any required corrective and preventive actions should be implemented. Chapter 7 adds, for outsourced activities, that the contract giver should monitor and review the contract acceptor's performance and the implementation of any needed improvement.
Neither chapter says how. In practice each observation gets a classification, so that a critical one cannot wait behind ten minor ones, and an action agreed with the supplier, with a date the supplier has accepted. The audit then stays open until someone has looked at the evidence: a revised procedure, a batch record, or a follow-up visit for the serious ones.
The link most often missing is the last one. Open actions should show against the supplier on the approved supplier list, where purchasing and QA both look. A supplier with an overdue critical action and a clean "approved" status is a contradiction anyone can read off one page.
Industries




